Targets and regulation of microRNA-652-3p in homoeostasis and disease

Maxwell T Stevens1, Bernadette M Saunders2,3

  • 1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.

Journal of Molecular Medicine (Berlin, Germany)
|March 13, 2021
PubMed

Insights

MicroRNA-652-3p regulates cell functions and is implicated in various diseases. This microRNA shows promise as a diagnostic biomarker and therapeutic target due to its broad cellular activity.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression by inhibiting mRNA translation.
  • miRNAs are increasingly recognized for their roles in cellular homeostasis and disease pathogenesis.
  • miR-652-3p is a specific miRNA with emerging roles in diverse physiological and pathological processes.

Purpose of the Study:

  • To review the current literature on microRNA-652-3p (miR-652-3p).
  • To discuss the known target genes of miR-652-3p and their relevance to disease progression.
  • To highlight the potential of miR-652-3p as a diagnostic and therapeutic target.

Main Methods:

  • Literature review of studies investigating miR-652-3p.
  • Analysis of reported target genes and their functional implications.
  • Synthesis of findings related to miR-652-3p's role in cancer, cardiovascular, mental health, and CNS diseases.

Main Results:

  • miR-652-3p targets LLGL1 and ZEB1, influencing cell polarity, cancer metastasis, and asymmetric cell division.
  • miR-652-3p inhibits JAG1, impacting angiogenesis and immune cell regulation.
  • Dysregulation of miR-652-3p is linked to multiple pathways involved in disease states.

Conclusions:

  • miR-652-3p plays diverse roles in normal cell function and disease.
  • Its ability to modulate key cellular processes makes it a significant research focus.
  • miR-652-3p demonstrates considerable potential as a biomarker and therapeutic agent.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.1K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
24.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K